JUVARIS BIOTHERAPEUTICS

juvaris-biotherapeutics-logo

Juvaris BioTherapeutics, Inc. is developing adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The Company's platform technology induces profound immunostimulation via cationic lipid-DNA (non-coding) complexes (CLDC). The Company's lead product candidate, JVRS-100, stimulates adaptive and innate immune responses at levels many fold higher than other drugs in its class. JVRS-100 is in clinical development as a vaccine adjuvant and an immunotherapeutic.

#SimilarOrganizations #People #Financial #Website #More

JUVARIS BIOTHERAPEUTICS

Industry:
Biotechnology Health Care Therapeutics

Founded:
2001-01-01

Address:
Burlingame, California, United States

Country:
United States

Website Url:
http://www.juvaris.com

Total Employee:
51+

Status:
Closed

Contact:
925-399-6200

Email Addresses:
[email protected]

Total Funding:
63.13 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Microsoft DNS Softlayer


Similar Organizations

alethia-biotherapeutics-logo

Alethia BioTherapeutics

Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.

corixa-logo

Corixa

Corixa is a developer of immunotherapeutics focused on treating and preventing autoimmune diseases, cancer and infectious diseases

galenea-logo

Galenea

Galenea is engaged in developing therapeutics for central nervous system diseases.

vaccinogen-logo

Vaccinogen

Vaccinogen manufactures vaccines and other immunotherapeutic products for cancers and infectious diseases.

Founder


jeff-fairman_image

Jeff Fairman

martin-d-cleary_image

Martin D. Cleary

steven-dow_image

Steven Dow

Investors List

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Series B - Juvaris BioTherapeutics

kleiner-perkins-caufield-byers_image

Kleiner Perkins

Kleiner Perkins investment in Series B - Juvaris BioTherapeutics

kleiner-perkins-caufield-byers_image

Kleiner Perkins

Kleiner Perkins investment in Series B - Juvaris BioTherapeutics

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Series B - Juvaris BioTherapeutics

kleiner-perkins-caufield-byers_image

Kleiner Perkins

Kleiner Perkins investment in Series A - Juvaris BioTherapeutics

Official Site Inspections

http://www.juvaris.com

  • Host name: 32.ce.0bc6.ip4.static.sl-reverse.com
  • IP address: 198.11.206.50
  • Location: San Jose United States
  • Latitude: 37.3388
  • Longitude: -121.8914
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 95141

Loading ...

More informations about "Juvaris BioTherapeutics" on Search Engine